Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

Jillian L. Kadota; Allan Musinguzi; Hélène E. Aschmann; Lydia Akello; Fred Welishe; Jane Nakimuli; Christopher A. Berger; Noah Kiwanuka; Patrick PJ Phillips; Achilles Katamba; David W. Dowdy; Adithya Cattamanchi; Fred C. Semitala

doi:10.1101/2024.08.08.24311632

Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

View ORCID ProfileJillian L. Kadota, View ORCID ProfileAllan Musinguzi, Hélène E. Aschmann, Lydia Akello, Fred Welishe, Jane Nakimuli, View ORCID ProfileChristopher A. Berger, View ORCID ProfileNoah Kiwanuka, View ORCID ProfilePatrick PJ Phillips, View ORCID ProfileAchilles Katamba, View ORCID ProfileDavid W. Dowdy, View ORCID ProfileAdithya Cattamanchi, View ORCID ProfileFred C. Semitala

doi: https://doi.org/10.1101/2024.08.08.24311632

Jillian L. Kadota

1Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA

2Center for Tuberculosis, University of California San Francisco, San Francisco CA USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jillian L. Kadota

Allan Musinguzi

3Infectious Diseases Research Collaboration, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Allan Musinguzi

Hélène E. Aschmann

1Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA

2Center for Tuberculosis, University of California San Francisco, San Francisco CA USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lydia Akello

3Infectious Diseases Research Collaboration, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Fred Welishe

3Infectious Diseases Research Collaboration, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jane Nakimuli

3Infectious Diseases Research Collaboration, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher A. Berger

1Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA

2Center for Tuberculosis, University of California San Francisco, San Francisco CA USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christopher A. Berger

Noah Kiwanuka

4Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Noah Kiwanuka

Patrick PJ Phillips

1Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco CA USA

2Center for Tuberculosis, University of California San Francisco, San Francisco CA USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Patrick PJ Phillips

Achilles Katamba

5Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

6Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Achilles Katamba

David W. Dowdy

7Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for David W. Dowdy

Adithya Cattamanchi

2Center for Tuberculosis, University of California San Francisco, San Francisco CA USA

9Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Orange CA USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Adithya Cattamanchi
For correspondence: acattama@hs.uci.edu

Fred C. Semitala

3Infectious Diseases Research Collaboration, Kampala, Uganda

8Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

10Makerere University Joint AIDS Program, Kampala, Uganda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fred C. Semitala

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data availability

Data not publicly available.

View the discussion thread.

PreviousNext

Posted August 09, 2024.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

Jillian L. Kadota, Allan Musinguzi, Hélène E. Aschmann, Lydia Akello, Fred Welishe, Jane Nakimuli, Christopher A. Berger, Noah Kiwanuka, Patrick PJ Phillips, Achilles Katamba, David W. Dowdy, Adithya Cattamanchi, Fred C. Semitala

medRxiv 2024.08.08.24311632; doi: https://doi.org/10.1101/2024.08.08.24311632

Share This Article:

Citation Tools

Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

medRxiv 2024.08.08.24311632; doi: https://doi.org/10.1101/2024.08.08.24311632

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Infectious Diseases (except HIV/AIDS)

Subject Areas

All Articles

Addiction Medicine (399)
Allergy and Immunology (708)
Anesthesia (201)
Cardiovascular Medicine (2923)
Dentistry and Oral Medicine (333)
Dermatology (249)
Emergency Medicine (439)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1032)
Epidemiology (12719)
Forensic Medicine (12)
Gastroenterology (827)
Genetic and Genomic Medicine (4571)
Geriatric Medicine (417)
Health Economics (729)
Health Informatics (2913)
Health Policy (1069)
Health Systems and Quality Improvement (1075)
Hematology (387)
HIV/AIDS (923)
Infectious Diseases (except HIV/AIDS) (14090)
Intensive Care and Critical Care Medicine (845)
Medical Education (423)
Medical Ethics (115)
Nephrology (468)
Neurology (4341)
Nursing (235)
Nutrition (637)
Obstetrics and Gynecology (802)
Occupational and Environmental Health (734)
Oncology (2264)
Ophthalmology (643)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (278)
Palliative Medicine (83)
Pathology (500)
Pediatrics (1196)
Pharmacology and Therapeutics (504)
Primary Care Research (495)
Psychiatry and Clinical Psychology (3743)
Public and Global Health (6923)
Radiology and Imaging (1524)
Rehabilitation Medicine and Physical Therapy (898)
Respiratory Medicine (915)
Rheumatology (437)
Sexual and Reproductive Health (443)
Sports Medicine (384)
Surgery (486)
Toxicology (60)
Transplantation (210)
Urology (179)